Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds




Posted on: 19 May 08


New book from informa Healthcare presents controlling lifestyle risk factors as best weapon to fight onset of Breast Cancer
NEW YORK—April 25th, 2008—informa Healthcare, one of the premier medical scientific publishers, published earlier this month a revised and updated Second Edition of its bestseller: Breast Cancer: Prognosis, Treatment, and Prevention.
According to the Global Cancer Facts and Figures report, in 2007 cancer killed some 7.6 million people around the world. By 2020 the World Health Organization estimates the cancer death rate will grow to 10 million per year. Breast cancer alone affects one in every nine women worldwide.
But there is hope. The rapid pace of research—whereby findings quickly are integrated into standard therapy and treatment protocols—promises significant developments which will save lives. This momentum makes it critical for professionals to continually keep pace with the latest breakthroughs in the field.
Edited by Professor Jorge R. Pasqualini—and with contributions from key opinion leaders around the world— Breast Cancer: Prognosis, Treatment, and Prevention compiles all the latest research findings along with the most innovative clinical diagnosis and treatment guidelines into one cohesive, comprehensive resource for physicians.
Breast Cancer: Prognosis, Treatment, and Prevention delivers the most up-to-date data on therapeutic strategies, prognostic and predictive factors, and prevention strategies – including the beneficial role of physical activity in the treatment and prevention of breast cancer. However, that’s not all; Breast Cancer also examines the biological, genetic, and molecular pathways linked to the development and progression of breast cancer—including new information on the mechanisms involved in carcinogenesis.
This book is available worldwide wherever medical books are sold. Or visit,
About the Editor
Jorge R. Pasqualini is a prolific author who has published over 600 original papers. Professor Pasqualini is the founder and Editor-in-Chief of The Journal of Steroid Biochemistry and Molecular Biology, considered to be one of the leading international scientific journals in its field.
Professor Pasqualini is Director of the Hormones and Cancer Research Unit at the Institut de Puériculture of Paris. He received his Ph.D. in biology from the University of Buenos Aires, Argentina, and a D.Sc. degree in Endocrinology from the University of Paris, France.
About informa Healthcare
informa Healthcare is a new force in science publishing that delivers authoritative research and analysis, up-to-the-minute news, comment and debate for all sectors of the Healthcare and Life Sciences communities. informa Healthcare serves the commercial needs of business leaders, the research needs of the scientific community and the 'good practice' needs of healthcare professionals around the world. The company, headquartered in London, England, is a division of Informa plc (London: INF) which employs 7,500 staff worldwide, and has offices in six continents. For more information, please visit # # #

Maria Pacheco

Last updated on: 27/08/2010 11:40:18

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.